Acknowledgement Letter from FDA DMB to Lowenstein Sandler on behalf of PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma

1 recorded connections shown. Select a record, office or person to follow its source references.

Start with

and connect to

Zoom to read. Drag to explore. Select a connection.

Rulemaking document · As of Jul 19, 2026

Rulemaking document

Acknowledgement Letter from FDA DMB to Lowenstein Sandler on behalf of PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma: 1 outgoing connections shown. Point at anyone to see how they are linked.Showing bounded source connections. Dates come from the held records; missing relationships remain unknown.

The source record

As of Jul 19, 2026.

Document type: Other
Subtype: Acknowledgement Letter/Receipt
Title: Acknowledgement Letter from FDA DMB to Lowenstein Sandler on behalf of PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma
Posted date: 2026-06-24T04:00:00+00:00
Comment start date: 2026-06-24T04:00:00+00:00
Last modified date: 2026-06-24T23:50:51+00:00
Within comment period: false
Open for comment: false
Withdrawn: false
Ingested at: 2026-07-19T04:05:19.467594+00:00

Every link on this map

The same connections as a table, with the reason each one is here.

Sort by

Connections of Acknowledgement Letter from FDA DMB to Lowenstein Sandler on behalf of PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma

Rulemaking document	What this connects to	Acknowledgement Letter from FDA DMB to Lowenstein Sandler on behalf of PAI Holdings, LLC dba Pharmaceutical Associates, Inc. and dba PAI Pharma has a recorded connection to Rulemaking document.	None